ADMI
GSK icon

Albert D. Mason Inc’s GSK GSK Stock Holding History

Albert D. Mason Inc’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-12,598
Closed -$656K – 126
2015
Q2 		$656K Sell
12,598
-90,270
-88% -$5.08M 0.35% 92
2015
Q1 		$5.93M Buy
102,868
+53,888
+110% +$3.09M 1.23% 28
2014
Q4 		$2.62M Buy
48,980
+1,720
+4% +$96.2K 0.52% 73
2014
Q3 		$2.72M Sell
47,260
-13,832
-23% -$848K 0.53% 76
2014
Q2 		$4.08M Buy
61,092
+1,940
+3% +$131K 0.74% 54
2014
Q1 		$3.95M Sell
59,152
-1,024
-2% -$69.2K 0.77% 53
2013
Q4 		$4.02M Buy
60,176
+3,956
+7% +$257K 0.79% 48
2013
Q3 		$3.53M Sell
56,220
-7,096
-11% -$457K 0.74% 53
2013
Q2 		$3.96M Buy
+63,316
New +$4.02M 0.87% 52

Other funds holding GSK

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Albert D. Mason Inc's GSK Position: Q3 2015 in Review

Albert D. Mason Inc sold out of GSK (GSK) in Q3 2015, closing a stake of 12,598 shares — an estimated $656K sold.

Albert D. Mason Inc first reported a position in GSK in Q2 2013 and held it in 9 quarters. The position peaked at $5.93M in Q1 2015. 706 funds tracked by Wall St. Rank hold GSK as of Q3 2015.

  • Albert D. Mason Inc reported no remaining GSK position as of Q3 2015 after selling out during the quarter.
  • Albert D. Mason Inc sold 12,598 GSK shares in Q3 2015, an estimated $656K.
  • Albert D. Mason Inc first reported a position in GSK in Q2 2013 and held it in 9 quarters.
  • Albert D. Mason Inc's GSK position peaked at $5.93M in Q1 2015.
  • 706 funds tracked by Wall St. Rank held GSK as of Q3 2015.

Based on Albert D. Mason Inc's 13F filing for Q3 2015, filed 13 Oct 2015.